Daniel J. Price

896 total citations
4 papers, 119 citations indexed

About

Daniel J. Price is a scholar working on Infectious Diseases, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Daniel J. Price has authored 4 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Pathology and Forensic Medicine and 2 papers in Hepatology. Recurrent topics in Daniel J. Price's work include Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Biochemical and Molecular Research (1 paper). Daniel J. Price is often cited by papers focused on Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Biochemical and Molecular Research (1 paper). Daniel J. Price collaborates with scholars based in United States. Daniel J. Price's co-authors include Andrew J. Peat, Andrew Maynard, Katrina L. Creech, Vincent W.‐F. Tai, Jeffrey J. Pouliot, J. Brad Shotwell, Elizabeth M. Turner, John F. Miller, Shawn P. Williams and Amanda Mathis and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Daniel J. Price

4 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Price United States	4	54	48	16	15	12	4	119
Steven G. Kultgen United States	7	87 1.6×	75 1.6×	24 1.5×	12 0.8×	28 2.3×	15	201
Javier de Vicente United States	6	46 0.9×	36 0.8×	9 0.6×	15 1.0×	8 0.7×	6	126
Robert A. Noe United States	4	43 0.8×	59 1.2×	14 0.9×	12 0.8×	34 2.8×	4	120
John King-Underwood United Kingdom	6	75 1.4×	18 0.4×	17 1.1×	20 1.3×	30 2.5×	7	223
Kevin D. Freeman‐Cook United States	5	101 1.9×	40 0.8×	12 0.8×	6 0.4×	7 0.6×	11	156
Andrew Thompson France	7	66 1.2×	13 0.3×	11 0.7×	9 0.6×	10 0.8×	11	98
C. Be Switzerland	4	63 1.2×	10 0.2×	11 0.7×	8 0.5×	8 0.7×	4	146
Emma Rose Scaletti Sweden	7	108 2.0×	36 0.8×	12 0.8×	15 1.0×	21 1.8×	15	193
Armando Cázares‐Körner Sweden	5	112 2.1×	32 0.7×	6 0.4×	17 1.1×	9 0.8×	5	151
Souradeep Basu United Kingdom	7	123 2.3×	21 0.4×	9 0.6×	31 2.1×	13 1.1×	8	203

Countries citing papers authored by Daniel J. Price

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Price more than expected).

Fields of papers citing papers by Daniel J. Price

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Price. The network helps show where Daniel J. Price may publish in the future.

Co-authorship network of co-authors of Daniel J. Price

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Price. A scholar is included among the top collaborators of Daniel J. Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Price. Daniel J. Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Chong, Pek Y., J. Brad Shotwell, John F. Miller, et al.. (2019). Design of N -Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. Journal of Medicinal Chemistry. 62(7). 3254–3267. 45 indexed citations

2.

Tsai, I-Chun, Spencer U. McKinstry, Andrew Maynard, et al.. (2018). Small molecule inhibition of RAS/MAPK signaling ameliorates developmental pathologies of Kabuki Syndrome. Scientific Reports. 8(1). 10779–10779. 27 indexed citations

3.

Tai, Vincent W.‐F., Dulce Garrido, Daniel J. Price, et al.. (2014). Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein. Bioorganic & Medicinal Chemistry Letters. 24(10). 2288–2294. 21 indexed citations

4.

Stevens, Kirk L., Michael J. Reno, Daniel J. Price, et al.. (2008). Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(21). 5758–5762. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact